Elevance Health Inc (ELV)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	-116,464,000	-115,079,000	-113,431,000	-110,955,000	-108,727,000	-106,057,000	-103,460,000	-99,234,000	-94,877,000	-36,155,000	-34,235,000	-28,229,000	-26,103,000	-30,520,000	-27,071,000	-29,608,000	-27,554,000	-31,588,000	-29,265,000	-26,567,500
Revenue (ttm)	US$ in thousands	171,340,000	168,622,000	165,712,000	160,672,000	156,595,000	153,247,000	149,130,000	144,349,000	138,639,000	133,882,000	129,218,000	124,631,000	121,867,000	117,450,000	112,966,000	109,168,000	104,213,000	100,179,000	96,756,000	94,234,000
Gross profit margin		-67.97%	-68.25%	-68.45%	-69.06%	-69.43%	-69.21%	-69.38%	-68.75%	-68.43%	-27.01%	-26.49%	-22.65%	-21.42%	-25.99%	-23.96%	-27.12%	-26.44%	-31.53%	-30.25%	-28.19%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-116,464,000K ÷ $171,340,000K
= -67.97%

Elevance Health Inc's gross profit margin has exhibited a consistent trend of slight fluctuations over the past eight quarters. The margins have ranged from a high of 91.97% in Q1 2022 to a low of 89.84% in Q4 2023. Despite the variability, the margins have generally remained high, reflecting the company's ability to effectively manage its production costs and generate significant revenue from its core business activities. This suggests that Elevance Health Inc has maintained a strong pricing strategy and operational efficiency in its cost structure. Monitoring these trends over time can provide valuable insights into the company's overall financial health and operational performance.